With the recent description of the QR2 pathway in the brain and its association with cognitive dysfunction and metabolic pathologies with age, we believe that an exceptional opportunity to tackle neurodegenerative diseases like AD has been found. The gene discussed is NQO2; the disease is neurodegenerative disease.